JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2014, Vol. 52 ›› Issue (12): 20-23.doi: 10.6040/j.issn.1671-7554.0.2014.172
Previous Articles Next Articles
CHEN Xianghong, LIU Yan, WENG Yuxin, KANG Wenjuan, YANG Shibing
CLC Number:
[1] 彭彤,梁慧,郭亦然,等.芜菁根挥发油化学成分的气相色谱-质谱联用分析[J].时珍国医国药, 2009, 20(12):3000-3002. PENG Tong, LIANG Hui, GUO Yiran, et al. Analysis on the volatile oils from Brassica rapa L. by GC-MS[J]. LISHIZHEN Medicine and Materia Medica Research, 2009, 20(12): 3000-3002. [2] 陈湘宏,文绍敦,吴萍,等.芜菁不同提取物对糖尿病模型小鼠降血糖作用的研究[J].中国药房, 2013, 24(7):596-598. CHEN Xianghong, WEN Shaodun, WU Ping. Study on hypoglycemic effect of different extracts of Brassica rapa on diabetic model mice[J]. China Pharmacy, 2013, 24(7):596-598. [3] 朱爱勤.糖尿病证治八型[J].黑龙江中医药, 2001(4):5-6. [4] Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening[J]. Pharmacological Research, 2005, 52(4):313-320. [5] Zhang M, Lv X Y, Li J, et al. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model[J]. Exp Diabetes Res, 2008, 2008:704045. [6] 刘文晖.早期糖尿病肾脏微血管病变对糖化血红蛋白及尿微量白蛋白水平的影响[J].临床合理用药, 2011, 4(3B):9-10. LIU Wenhui. Effect of early diabetic renal microangiopathy with glycated hemoglobin (HbAlc) and urinary microproteins[J]. Chin J of Clinical Rational Drug Use, 2011, 4(3B):9-10. [7] Yamato T, Nakamura T, Nobel N A, et al. Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy [J]. Proc Natl Acad Sci U S A, 1993, 90(5):1814-1818. [8] Yamato T, Nobel N A, Cohen A H, et al. Expression of transforming growth factor-beta isofomns in human glomerular diseases[J]. Kidney Int, 1996, 49(2):461-469. [9] Shankland S J, Scholey J W, Ly H, et al. Expression oftransforming growth factor-β1 during diabetic renal hypertrophy [J]. Kidney Int, 1994, 46(6):430-432. [10] 苏丽.糖化血红蛋白与糖尿病及其并发症的相关性探讨[J].临床和实验医学杂志, 2011, 10(10):771-772. [11] Eckel R H, York D A, Rossner S, et al. Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: executive summary[J]. Circulation, 2004, 110(18):2968-2975. [12] Barnett A H. Dyslipidaemia in diabetes—a GP guide[J]. Practitioner, 2002, 246 (1631):120-123. [13] Smith S R, Ravussin E. Emerging paradigms for understanding fatness and diabetes risk[J]. Curr Diab Rep, 2002, 2(3): 223-230. [14] Unger R H. Lipotoxic diseases[J]. Annu Rev Med, 2002, 53:319-336. [15] Aissaoui A, Zizi S, Israili Z H, et al. Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats[J]. J Ethnopharmacol, 2011, 137(1): 652-661. |
[1] | ZHANG Nan1, YUAN Zhongshang2, ZHANG Xu1, ZHANG Yikun1, YU Chunxiao1, GAO Ling3, ZHAO Jiajun1, GUAN Qingbo1, GUAN Liying4. Association between serum testosterone and lipid profile in men with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 58-61. |
[2] | GUO Ya-di, GAO Yan-yan, LI Li, SUN Rui-xia, WANG Jing, XIAN Yu-xin. Effects of lansoprazole therapy on the plasma glucose and gastrin in the patients with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 62-66. |
[3] | YIN Xiaofang, HOU Xinguo, SUN Yu, JIAO Lei, LIU Qinghong,MA Aixia, FAN Linlin, ZHANG Liang, CAO Lijun, CHEN Li. Investigation of glycosylated hemoglobin A1c control and its influencing factors in type 2 diabetic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(1): 12-16. |
|